Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F D Goebel

Infection

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Infection|March 8, 2005
Immune reconstitution inflammatory syndrome (IRIS)--another new disease entity following treatment initiation of HIV infectionF D Goebel
Infection|December 31, 2004
Can science solve the global AIDS problem?F D Goebel
Infection|December 15, 2004
HAART-prolonged life of HIV-infected patients should not be shortened by hepatitis CS Horster, F D Goebel
Infection|June 9, 2005
Susceptibility to HIV/AIDS: an individual characteristic we can measure?B Jülg, F D Goebel
Infection|June 10, 2004
How to start antiretroviral therapy?S Horster, F-D Goebel
Infection|October 13, 2006
Clinical news from the XVI International AIDS Conference: The attempt of a summing upB Jülg, F D Goebel
Infection|May 17, 2006
Serious doubts on safety and efficacy of CCR5 antagonists : CCR5 antagonists teeter on a knife-edgeS Horster, F D Goebel
Infection|June 29, 2006
Treatment interruption in HIV therapy: a SMART strategy?B Jülg, F D Goebel
Infection|August 11, 2005
HIV genetic diversity: any implications for drug resistance?B Jülg, F D Goebel
Infection|November 1, 2005
What's New in HIV/AIDS? Chemokine receptor antagonists: a new era of HIV therapy?B Jülg, F D Goebel
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Infection|March 8, 2005
Immune reconstitution inflammatory syndrome (IRIS)--another new disease entity following treatment initiation of HIV infectionF D Goebel
Infection|December 31, 2004
Can science solve the global AIDS problem?F D Goebel
Infection|December 15, 2004
HAART-prolonged life of HIV-infected patients should not be shortened by hepatitis CS Horster, F D Goebel
Infection|June 9, 2005
Susceptibility to HIV/AIDS: an individual characteristic we can measure?B Jülg, F D Goebel
Infection|June 10, 2004
How to start antiretroviral therapy?S Horster, F-D Goebel
Infection|October 13, 2006
Clinical news from the XVI International AIDS Conference: The attempt of a summing upB Jülg, F D Goebel
Infection|May 17, 2006
Serious doubts on safety and efficacy of CCR5 antagonists : CCR5 antagonists teeter on a knife-edgeS Horster, F D Goebel
Infection|June 29, 2006
Treatment interruption in HIV therapy: a SMART strategy?B Jülg, F D Goebel
Infection|August 11, 2005
HIV genetic diversity: any implications for drug resistance?B Jülg, F D Goebel
Infection|November 1, 2005
What's New in HIV/AIDS? Chemokine receptor antagonists: a new era of HIV therapy?B Jülg, F D Goebel
Pageof 2